Tuesday, May 02, 2017

Pricing is suspiciously absent from the Health Insurance Debate



Why is it that the “healthcare debate” is always about Insurance premiums/deductibles and not about the “prices of goods and services”? Generic drugs prices - where there is no R&D expense – have recently risen into the hundreds of dollars, where they used to be $2-$5 a prescription. A hospital will give an estimate of their base charge for an inpatient procedure, but once you are home you get 30 bills for doctors and tests, which end up running the bill 2-3X more than anticipated. The public is caught between huge Hospital conglomerates (posing somehow as non-profits) who gouge their patients, drug companies that charge obscene prices with no justification, an FDA that seems complicit in this abuse of the public, and insurance companies. Until pricing is front in center in the healthcare debate the issue will never be resolved. Health Insurance premiums are directly related to the price gouging committed by the “industry”.  The proof is in the fact that a person with no insurance can negotiate a better price for prescription drugs (drug company discount cards) than a person who has health insurance with a conglomerate that has a million people in their pool. There is a lot of political lobbying muscle in the AMA, Health Insurance industry, drug companies and hospital conglomerates. Who is lobbying for the patients?

No comments: